Insilico Medicine And SK Biopharmaceuticals to collaborate in $2.5bn deal
Kither Biotech completes phase 1 trial of inhaled peptide therapy for respiratory diseases
Houdini Bio launches to solve therapeutic and commercial genetic medicine bottlenecks
Base to Base biotech podcast 64: Solving logistics challenges
Investigational treatment of autosomal dominant polycystic kidney disease receives orphan drug designation
World’s first gene-editing therapy for hyperlipidemia
Positive results for Lilly obesity drug
“Foundational moment for in vivo cell therapy”
Cooperative motor proteins kill cancer cells when dual-inhibited
SanegeneBio announces collaboration with Lilly
Amgen reveals cardiovascular drug results
Pila Pharma’s capital raise oversubscribed by 293% to fund obesity studies